nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP2E1—Etoposide—testicular cancer	0.0267	0.327	CbGbCtD
Aminophylline—CYP3A4—Ifosfamide—testicular cancer	0.0169	0.207	CbGbCtD
Aminophylline—CYP1A2—Etoposide—testicular cancer	0.0155	0.189	CbGbCtD
Aminophylline—HDAC2—Teniposide—Etoposide—testicular cancer	0.0128	1	CbGdCrCtD
Aminophylline—CYP3A4—Vinblastine—testicular cancer	0.00899	0.11	CbGbCtD
Aminophylline—CYP3A4—Etoposide—testicular cancer	0.0081	0.0991	CbGbCtD
Aminophylline—CYP3A4—Doxorubicin—testicular cancer	0.00552	0.0676	CbGbCtD
Aminophylline—HDAC2—embryo—testicular cancer	0.0054	0.102	CbGeAlD
Aminophylline—ADORA2A—gonad—testicular cancer	0.0043	0.0814	CbGeAlD
Aminophylline—ADORA2B—G alpha (s) signalling events—INSL3—testicular cancer	0.00398	0.0641	CbGpPWpGaD
Aminophylline—PDE4A—female gonad—testicular cancer	0.00374	0.0708	CbGeAlD
Aminophylline—ADORA2B—testis—testicular cancer	0.00372	0.0705	CbGeAlD
Aminophylline—HDAC2—gonad—testicular cancer	0.00367	0.0694	CbGeAlD
Aminophylline—PDE4A—G alpha (s) signalling events—INSL3—testicular cancer	0.00362	0.0582	CbGpPWpGaD
Aminophylline—PDE3A—G alpha (s) signalling events—INSL3—testicular cancer	0.00352	0.0567	CbGpPWpGaD
Aminophylline—PDE4A—testis—testicular cancer	0.00332	0.0628	CbGeAlD
Aminophylline—ADORA2A—testis—testicular cancer	0.0031	0.0587	CbGeAlD
Aminophylline—PDE3A—female gonad—testicular cancer	0.0031	0.0586	CbGeAlD
Aminophylline—HDAC2—female gonad—testicular cancer	0.00298	0.0564	CbGeAlD
Aminophylline—PDE3A—testis—testicular cancer	0.00275	0.052	CbGeAlD
Aminophylline—ADORA1—testis—testicular cancer	0.00268	0.0506	CbGeAlD
Aminophylline—HDAC2—testis—testicular cancer	0.00264	0.05	CbGeAlD
Aminophylline—ADORA2A—G alpha (s) signalling events—INSL3—testicular cancer	0.00261	0.0421	CbGpPWpGaD
Aminophylline—HDAC2—Epigenetic regulation of gene expression—DNMT3L—testicular cancer	0.00261	0.042	CbGpPWpGaD
Aminophylline—ADORA2B—C-MYB transcription factor network—MAD1L1—testicular cancer	0.0025	0.0402	CbGpPWpGaD
Aminophylline—PDE4A—lymph node—testicular cancer	0.00241	0.0455	CbGeAlD
Aminophylline—Haematemesis—Doxorubicin—testicular cancer	0.00215	0.00272	CcSEcCtD
Aminophylline—CYP2E1—seminal vesicle—testicular cancer	0.0021	0.0397	CbGeAlD
Aminophylline—Convulsion—Chlorambucil—testicular cancer	0.00209	0.00264	CcSEcCtD
Aminophylline—Hypokalaemia—Cisplatin—testicular cancer	0.00208	0.00263	CcSEcCtD
Aminophylline—Hyperglycaemia—Ifosfamide—testicular cancer	0.00206	0.00261	CcSEcCtD
Aminophylline—Ventricular arrhythmia—Doxorubicin—testicular cancer	0.00202	0.00255	CcSEcCtD
Aminophylline—Albuminuria—Doxorubicin—testicular cancer	0.002	0.00253	CcSEcCtD
Aminophylline—PDE3A—lymph node—testicular cancer	0.00199	0.0377	CbGeAlD
Aminophylline—Flushing—Bleomycin—testicular cancer	0.00199	0.00252	CcSEcCtD
Aminophylline—Extravasation—Methotrexate—testicular cancer	0.00198	0.0025	CcSEcCtD
Aminophylline—Infection—Chlorambucil—testicular cancer	0.00195	0.00247	CcSEcCtD
Aminophylline—Haematuria—Ifosfamide—testicular cancer	0.00195	0.00246	CcSEcCtD
Aminophylline—ADORA1—lymph node—testicular cancer	0.00194	0.0367	CbGeAlD
Aminophylline—HDAC2—lymph node—testicular cancer	0.00192	0.0363	CbGeAlD
Aminophylline—Convulsion—Vinblastine—testicular cancer	0.00191	0.00242	CcSEcCtD
Aminophylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.0019	0.0306	CbGpPWpGaD
Aminophylline—Alopecia—Bleomycin—testicular cancer	0.00189	0.0024	CcSEcCtD
Aminophylline—Anorexia—Chlorambucil—testicular cancer	0.00188	0.00237	CcSEcCtD
Aminophylline—Hyperuricaemia—Methotrexate—testicular cancer	0.00186	0.00235	CcSEcCtD
Aminophylline—Flushing—Dactinomycin—testicular cancer	0.00186	0.00235	CcSEcCtD
Aminophylline—Extravasation—Epirubicin—testicular cancer	0.00185	0.00234	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Epirubicin—testicular cancer	0.00179	0.00226	CcSEcCtD
Aminophylline—Alopecia—Dactinomycin—testicular cancer	0.00177	0.00223	CcSEcCtD
Aminophylline—Blood uric acid increased—Methotrexate—testicular cancer	0.00176	0.00222	CcSEcCtD
Aminophylline—Hyperuricaemia—Epirubicin—testicular cancer	0.00174	0.0022	CcSEcCtD
Aminophylline—ADORA2B—C-MYB transcription factor network—H2AFZ—testicular cancer	0.00174	0.028	CbGpPWpGaD
Aminophylline—Dyspepsia—Chlorambucil—testicular cancer	0.00173	0.00219	CcSEcCtD
Aminophylline—Anorexia—Vinblastine—testicular cancer	0.00172	0.00217	CcSEcCtD
Aminophylline—Extravasation—Doxorubicin—testicular cancer	0.00171	0.00217	CcSEcCtD
Aminophylline—Decreased appetite—Chlorambucil—testicular cancer	0.00171	0.00216	CcSEcCtD
Aminophylline—Flushing—Ifosfamide—testicular cancer	0.0017	0.00215	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Doxorubicin—testicular cancer	0.00165	0.00209	CcSEcCtD
Aminophylline—Skin exfoliation—Methotrexate—testicular cancer	0.00165	0.00208	CcSEcCtD
Aminophylline—Blood uric acid increased—Epirubicin—testicular cancer	0.00164	0.00208	CcSEcCtD
Aminophylline—Arrhythmia—Ifosfamide—testicular cancer	0.00164	0.00207	CcSEcCtD
Aminophylline—Alopecia—Ifosfamide—testicular cancer	0.00162	0.00205	CcSEcCtD
Aminophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00161	0.026	CbGpPWpGaD
Aminophylline—Hyperuricaemia—Doxorubicin—testicular cancer	0.00161	0.00204	CcSEcCtD
Aminophylline—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00161	0.00204	CcSEcCtD
Aminophylline—ADORA2B—C-MYB transcription factor network—KITLG—testicular cancer	0.0016	0.0258	CbGpPWpGaD
Aminophylline—Dermatitis contact—Epirubicin—testicular cancer	0.0016	0.00202	CcSEcCtD
Aminophylline—Coma—Methotrexate—testicular cancer	0.00158	0.00199	CcSEcCtD
Aminophylline—Decreased appetite—Vinblastine—testicular cancer	0.00157	0.00198	CcSEcCtD
Aminophylline—Urticaria—Chlorambucil—testicular cancer	0.00156	0.00198	CcSEcCtD
Aminophylline—Abdominal pain—Chlorambucil—testicular cancer	0.00156	0.00197	CcSEcCtD
Aminophylline—Body temperature increased—Chlorambucil—testicular cancer	0.00156	0.00197	CcSEcCtD
Aminophylline—Skin exfoliation—Epirubicin—testicular cancer	0.00154	0.00195	CcSEcCtD
Aminophylline—Anaphylactic shock—Bleomycin—testicular cancer	0.00152	0.00193	CcSEcCtD
Aminophylline—Blood uric acid increased—Doxorubicin—testicular cancer	0.00152	0.00193	CcSEcCtD
Aminophylline—Infection—Bleomycin—testicular cancer	0.00151	0.00191	CcSEcCtD
Aminophylline—HDAC2—Cell Cycle—MAD1L1—testicular cancer	0.00151	0.0243	CbGpPWpGaD
Aminophylline—Dermatitis contact—Doxorubicin—testicular cancer	0.00148	0.00187	CcSEcCtD
Aminophylline—Coma—Epirubicin—testicular cancer	0.00148	0.00187	CcSEcCtD
Aminophylline—Gastrointestinal pain—Vinblastine—testicular cancer	0.00147	0.00187	CcSEcCtD
Aminophylline—Flushing—Cisplatin—testicular cancer	0.00147	0.00185	CcSEcCtD
Aminophylline—Agitation—Ifosfamide—testicular cancer	0.00147	0.00185	CcSEcCtD
Aminophylline—Anorexia—Bleomycin—testicular cancer	0.00145	0.00184	CcSEcCtD
Aminophylline—Hypersensitivity—Chlorambucil—testicular cancer	0.00145	0.00183	CcSEcCtD
Aminophylline—ADORA2B—GPCR ligand binding—INSL3—testicular cancer	0.00145	0.0233	CbGpPWpGaD
Aminophylline—Polyuria—Methotrexate—testicular cancer	0.00143	0.0018	CcSEcCtD
Aminophylline—Skin exfoliation—Doxorubicin—testicular cancer	0.00143	0.0018	CcSEcCtD
Aminophylline—Abdominal pain—Vinblastine—testicular cancer	0.00143	0.0018	CcSEcCtD
Aminophylline—Hypotension—Bleomycin—testicular cancer	0.00142	0.0018	CcSEcCtD
Aminophylline—Infection—Dactinomycin—testicular cancer	0.00141	0.00178	CcSEcCtD
Aminophylline—Arrhythmia—Cisplatin—testicular cancer	0.00141	0.00178	CcSEcCtD
Aminophylline—Palpitations—Ifosfamide—testicular cancer	0.00141	0.00178	CcSEcCtD
Aminophylline—Alopecia—Cisplatin—testicular cancer	0.0014	0.00177	CcSEcCtD
Aminophylline—Pruritus—Chlorambucil—testicular cancer	0.00139	0.00176	CcSEcCtD
Aminophylline—Convulsion—Ifosfamide—testicular cancer	0.00138	0.00175	CcSEcCtD
Aminophylline—Coma—Doxorubicin—testicular cancer	0.00137	0.00173	CcSEcCtD
Aminophylline—Phlebitis—Epirubicin—testicular cancer	0.00136	0.00172	CcSEcCtD
Aminophylline—Anorexia—Dactinomycin—testicular cancer	0.00135	0.00171	CcSEcCtD
Aminophylline—Diarrhoea—Chlorambucil—testicular cancer	0.00135	0.0017	CcSEcCtD
Aminophylline—Flushing—Etoposide—testicular cancer	0.00134	0.0017	CcSEcCtD
Aminophylline—Hypersensitivity—Vinblastine—testicular cancer	0.00133	0.00168	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Methotrexate—testicular cancer	0.00133	0.00168	CcSEcCtD
Aminophylline—Decreased appetite—Bleomycin—testicular cancer	0.00132	0.00167	CcSEcCtD
Aminophylline—Anaphylactic shock—Ifosfamide—testicular cancer	0.0013	0.00165	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00129	0.00164	CcSEcCtD
Aminophylline—Infection—Ifosfamide—testicular cancer	0.00129	0.00164	CcSEcCtD
Aminophylline—Tremor—Cisplatin—testicular cancer	0.00129	0.00163	CcSEcCtD
Aminophylline—Alopecia—Etoposide—testicular cancer	0.00128	0.00162	CcSEcCtD
Aminophylline—Nervous system disorder—Ifosfamide—testicular cancer	0.00128	0.00161	CcSEcCtD
Aminophylline—Phlebitis—Doxorubicin—testicular cancer	0.00126	0.00159	CcSEcCtD
Aminophylline—Vomiting—Chlorambucil—testicular cancer	0.00125	0.00158	CcSEcCtD
Aminophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00125	0.0201	CbGpPWpGaD
Aminophylline—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00124	0.00157	CcSEcCtD
Aminophylline—Anorexia—Ifosfamide—testicular cancer	0.00124	0.00157	CcSEcCtD
Aminophylline—Decreased appetite—Dactinomycin—testicular cancer	0.00123	0.00156	CcSEcCtD
Aminophylline—Diarrhoea—Vinblastine—testicular cancer	0.00123	0.00156	CcSEcCtD
Aminophylline—ADORA1—GPCR ligand binding—INSL3—testicular cancer	0.00123	0.0198	CbGpPWpGaD
Aminophylline—Hypotension—Ifosfamide—testicular cancer	0.00122	0.00154	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00121	0.00153	CcSEcCtD
Aminophylline—Urticaria—Bleomycin—testicular cancer	0.00121	0.00153	CcSEcCtD
Aminophylline—Body temperature increased—Bleomycin—testicular cancer	0.0012	0.00152	CcSEcCtD
Aminophylline—Irritability—Methotrexate—testicular cancer	0.0012	0.00151	CcSEcCtD
Aminophylline—Dizziness—Vinblastine—testicular cancer	0.00119	0.00151	CcSEcCtD
Aminophylline—Convulsion—Cisplatin—testicular cancer	0.00119	0.00151	CcSEcCtD
Aminophylline—Nausea—Chlorambucil—testicular cancer	0.00117	0.00148	CcSEcCtD
Aminophylline—Anxiety—Cisplatin—testicular cancer	0.00117	0.00148	CcSEcCtD
Aminophylline—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00116	0.00147	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00115	0.00145	CcSEcCtD
Aminophylline—Vomiting—Vinblastine—testicular cancer	0.00115	0.00145	CcSEcCtD
Aminophylline—Decreased appetite—Ifosfamide—testicular cancer	0.00113	0.00143	CcSEcCtD
Aminophylline—Headache—Vinblastine—testicular cancer	0.00113	0.00143	CcSEcCtD
Aminophylline—Abdominal pain—Dactinomycin—testicular cancer	0.00112	0.00142	CcSEcCtD
Aminophylline—Body temperature increased—Dactinomycin—testicular cancer	0.00112	0.00142	CcSEcCtD
Aminophylline—Anaphylactic shock—Cisplatin—testicular cancer	0.00112	0.00142	CcSEcCtD
Aminophylline—Hypersensitivity—Bleomycin—testicular cancer	0.00112	0.00142	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00112	0.00142	CcSEcCtD
Aminophylline—Infection—Cisplatin—testicular cancer	0.00111	0.00141	CcSEcCtD
Aminophylline—Nervous system disorder—Cisplatin—testicular cancer	0.0011	0.00139	CcSEcCtD
Aminophylline—Tachycardia—Cisplatin—testicular cancer	0.0011	0.00139	CcSEcCtD
Aminophylline—CYP2E1—testis—testicular cancer	0.00109	0.0207	CbGeAlD
Aminophylline—ADORA2B—C-MYB transcription factor network—KIT—testicular cancer	0.00109	0.0176	CbGpPWpGaD
Aminophylline—Convulsion—Etoposide—testicular cancer	0.00109	0.00138	CcSEcCtD
Aminophylline—Pruritus—Bleomycin—testicular cancer	0.00108	0.00136	CcSEcCtD
Aminophylline—Nausea—Vinblastine—testicular cancer	0.00107	0.00135	CcSEcCtD
Aminophylline—Abdominal pain upper—Epirubicin—testicular cancer	0.00107	0.00135	CcSEcCtD
Aminophylline—Anorexia—Cisplatin—testicular cancer	0.00107	0.00135	CcSEcCtD
Aminophylline—Hypokalaemia—Epirubicin—testicular cancer	0.00107	0.00135	CcSEcCtD
Aminophylline—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00106	0.00135	CcSEcCtD
Aminophylline—HDAC2—NoRC negatively regulates rRNA expression—H2AFZ—testicular cancer	0.00105	0.017	CbGpPWpGaD
Aminophylline—Hypotension—Cisplatin—testicular cancer	0.00105	0.00133	CcSEcCtD
Aminophylline—Hypersensitivity—Dactinomycin—testicular cancer	0.00105	0.00132	CcSEcCtD
Aminophylline—Urticaria—Ifosfamide—testicular cancer	0.00103	0.00131	CcSEcCtD
Aminophylline—Abdominal pain—Ifosfamide—testicular cancer	0.00103	0.0013	CcSEcCtD
Aminophylline—Body temperature increased—Ifosfamide—testicular cancer	0.00103	0.0013	CcSEcCtD
Aminophylline—HDAC2—RNA Polymerase I Promoter Clearance—H2AFZ—testicular cancer	0.00103	0.0166	CbGpPWpGaD
Aminophylline—HDAC2—Negative epigenetic regulation of rRNA expression—H2AFZ—testicular cancer	0.00103	0.0166	CbGpPWpGaD
Aminophylline—Anaphylactic shock—Etoposide—testicular cancer	0.00103	0.0013	CcSEcCtD
Aminophylline—Infection—Etoposide—testicular cancer	0.00102	0.00129	CcSEcCtD
Aminophylline—HDAC2—RNA Polymerase I Transcription—H2AFZ—testicular cancer	0.00101	0.0163	CbGpPWpGaD
Aminophylline—Tachycardia—Etoposide—testicular cancer	0.001	0.00127	CcSEcCtD
Aminophylline—Abdominal pain upper—Doxorubicin—testicular cancer	0.000991	0.00125	CcSEcCtD
Aminophylline—Hypokalaemia—Doxorubicin—testicular cancer	0.000987	0.00125	CcSEcCtD
Aminophylline—Anorexia—Etoposide—testicular cancer	0.00098	0.00124	CcSEcCtD
Aminophylline—Decreased appetite—Cisplatin—testicular cancer	0.000975	0.00123	CcSEcCtD
Aminophylline—Diarrhoea—Dactinomycin—testicular cancer	0.000972	0.00123	CcSEcCtD
Aminophylline—HDAC2—Cell Cycle—KITLG—testicular cancer	0.000968	0.0156	CbGpPWpGaD
Aminophylline—Vomiting—Bleomycin—testicular cancer	0.000968	0.00122	CcSEcCtD
Aminophylline—Hypotension—Etoposide—testicular cancer	0.000961	0.00122	CcSEcCtD
Aminophylline—Rash—Bleomycin—testicular cancer	0.00096	0.00121	CcSEcCtD
Aminophylline—Dermatitis—Bleomycin—testicular cancer	0.000959	0.00121	CcSEcCtD
Aminophylline—Hypersensitivity—Ifosfamide—testicular cancer	0.000959	0.00121	CcSEcCtD
Aminophylline—ADORA2A—GPCR ligand binding—INSL3—testicular cancer	0.000949	0.0153	CbGpPWpGaD
Aminophylline—Pruritus—Ifosfamide—testicular cancer	0.000921	0.00116	CcSEcCtD
Aminophylline—Haematuria—Methotrexate—testicular cancer	0.000921	0.00116	CcSEcCtD
Aminophylline—Hyperglycaemia—Epirubicin—testicular cancer	0.000914	0.00116	CcSEcCtD
Aminophylline—HDAC2—Epigenetic regulation of gene expression—H2AFZ—testicular cancer	0.000912	0.0147	CbGpPWpGaD
Aminophylline—Nausea—Bleomycin—testicular cancer	0.000905	0.00114	CcSEcCtD
Aminophylline—Vomiting—Dactinomycin—testicular cancer	0.000903	0.00114	CcSEcCtD
Aminophylline—Rash—Dactinomycin—testicular cancer	0.000896	0.00113	CcSEcCtD
Aminophylline—Decreased appetite—Etoposide—testicular cancer	0.000894	0.00113	CcSEcCtD
Aminophylline—Diarrhoea—Ifosfamide—testicular cancer	0.000891	0.00113	CcSEcCtD
Aminophylline—Body temperature increased—Cisplatin—testicular cancer	0.000887	0.00112	CcSEcCtD
Aminophylline—Haematuria—Epirubicin—testicular cancer	0.000861	0.00109	CcSEcCtD
Aminophylline—Dizziness—Ifosfamide—testicular cancer	0.000861	0.00109	CcSEcCtD
Aminophylline—Hyperglycaemia—Doxorubicin—testicular cancer	0.000846	0.00107	CcSEcCtD
Aminophylline—Nausea—Dactinomycin—testicular cancer	0.000844	0.00107	CcSEcCtD
Aminophylline—Gastrointestinal pain—Etoposide—testicular cancer	0.000841	0.00106	CcSEcCtD
Aminophylline—Vomiting—Ifosfamide—testicular cancer	0.000828	0.00105	CcSEcCtD
Aminophylline—Hypersensitivity—Cisplatin—testicular cancer	0.000827	0.00105	CcSEcCtD
Aminophylline—Rash—Ifosfamide—testicular cancer	0.000821	0.00104	CcSEcCtD
Aminophylline—Dermatitis—Ifosfamide—testicular cancer	0.00082	0.00104	CcSEcCtD
Aminophylline—ADORA2B—GPCR downstream signaling—INSL3—testicular cancer	0.000817	0.0132	CbGpPWpGaD
Aminophylline—Urticaria—Etoposide—testicular cancer	0.000817	0.00103	CcSEcCtD
Aminophylline—Abdominal pain—Etoposide—testicular cancer	0.000813	0.00103	CcSEcCtD
Aminophylline—Body temperature increased—Etoposide—testicular cancer	0.000813	0.00103	CcSEcCtD
Aminophylline—HDAC2—RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription—H2AFZ—testicular cancer	0.000808	0.013	CbGpPWpGaD
Aminophylline—Haematuria—Doxorubicin—testicular cancer	0.000797	0.00101	CcSEcCtD
Aminophylline—Nausea—Ifosfamide—testicular cancer	0.000773	0.000978	CcSEcCtD
Aminophylline—Diarrhoea—Cisplatin—testicular cancer	0.000768	0.000971	CcSEcCtD
Aminophylline—Alopecia—Methotrexate—testicular cancer	0.000766	0.000969	CcSEcCtD
Aminophylline—Hypersensitivity—Etoposide—testicular cancer	0.000757	0.000958	CcSEcCtD
Aminophylline—Flushing—Epirubicin—testicular cancer	0.000753	0.000952	CcSEcCtD
Aminophylline—ADORA2B—Signaling by GPCR—INSL3—testicular cancer	0.000742	0.012	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—INSL3—testicular cancer	0.000742	0.0119	CbGpPWpGaD
Aminophylline—Pruritus—Etoposide—testicular cancer	0.000727	0.00092	CcSEcCtD
Aminophylline—HDAC2—Neural Crest Differentiation—FGFR3—testicular cancer	0.000725	0.0117	CbGpPWpGaD
Aminophylline—Arrhythmia—Epirubicin—testicular cancer	0.000725	0.000917	CcSEcCtD
Aminophylline—PDE3A—GPCR downstream signaling—INSL3—testicular cancer	0.000722	0.0116	CbGpPWpGaD
Aminophylline—Alopecia—Epirubicin—testicular cancer	0.000717	0.000907	CcSEcCtD
Aminophylline—Vomiting—Cisplatin—testicular cancer	0.000713	0.000902	CcSEcCtD
Aminophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	0.000711	0.0115	CbGpPWpGaD
Aminophylline—Rash—Cisplatin—testicular cancer	0.000707	0.000895	CcSEcCtD
Aminophylline—Dermatitis—Cisplatin—testicular cancer	0.000707	0.000894	CcSEcCtD
Aminophylline—Diarrhoea—Etoposide—testicular cancer	0.000703	0.00089	CcSEcCtD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000703	0.0113	CbGpPWpGaD
Aminophylline—Flushing—Doxorubicin—testicular cancer	0.000696	0.000881	CcSEcCtD
Aminophylline—ADORA1—GPCR downstream signaling—INSL3—testicular cancer	0.000695	0.0112	CbGpPWpGaD
Aminophylline—Tension—Epirubicin—testicular cancer	0.000693	0.000876	CcSEcCtD
Aminophylline—Nervousness—Epirubicin—testicular cancer	0.000686	0.000867	CcSEcCtD
Aminophylline—Dizziness—Etoposide—testicular cancer	0.00068	0.00086	CcSEcCtD
Aminophylline—PDE4A—Signaling by GPCR—INSL3—testicular cancer	0.000674	0.0109	CbGpPWpGaD
Aminophylline—Arrhythmia—Doxorubicin—testicular cancer	0.00067	0.000848	CcSEcCtD
Aminophylline—Nausea—Cisplatin—testicular cancer	0.000666	0.000843	CcSEcCtD
Aminophylline—Alopecia—Doxorubicin—testicular cancer	0.000663	0.000839	CcSEcCtD
Aminophylline—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000657	0.0106	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—INSL3—testicular cancer	0.000655	0.0106	CbGpPWpGaD
Aminophylline—Convulsion—Methotrexate—testicular cancer	0.000654	0.000827	CcSEcCtD
Aminophylline—Vomiting—Etoposide—testicular cancer	0.000654	0.000827	CcSEcCtD
Aminophylline—Agitation—Epirubicin—testicular cancer	0.000649	0.000821	CcSEcCtD
Aminophylline—Rash—Etoposide—testicular cancer	0.000648	0.00082	CcSEcCtD
Aminophylline—Dermatitis—Etoposide—testicular cancer	0.000648	0.000819	CcSEcCtD
Aminophylline—Headache—Etoposide—testicular cancer	0.000644	0.000815	CcSEcCtD
Aminophylline—Tension—Doxorubicin—testicular cancer	0.000641	0.000811	CcSEcCtD
Aminophylline—Nervousness—Doxorubicin—testicular cancer	0.000634	0.000803	CcSEcCtD
Aminophylline—ADORA1—Signaling by GPCR—INSL3—testicular cancer	0.000631	0.0102	CbGpPWpGaD
Aminophylline—Palpitations—Epirubicin—testicular cancer	0.000624	0.000789	CcSEcCtD
Aminophylline—Anaphylactic shock—Methotrexate—testicular cancer	0.000616	0.000779	CcSEcCtD
Aminophylline—Convulsion—Epirubicin—testicular cancer	0.000612	0.000774	CcSEcCtD
Aminophylline—Infection—Methotrexate—testicular cancer	0.000612	0.000774	CcSEcCtD
Aminophylline—Nausea—Etoposide—testicular cancer	0.000611	0.000772	CcSEcCtD
Aminophylline—Nervous system disorder—Methotrexate—testicular cancer	0.000604	0.000764	CcSEcCtD
Aminophylline—Agitation—Doxorubicin—testicular cancer	0.0006	0.000759	CcSEcCtD
Aminophylline—Anxiety—Epirubicin—testicular cancer	0.000599	0.000758	CcSEcCtD
Aminophylline—Anorexia—Methotrexate—testicular cancer	0.000587	0.000742	CcSEcCtD
Aminophylline—Palpitations—Doxorubicin—testicular cancer	0.000577	0.00073	CcSEcCtD
Aminophylline—Anaphylactic shock—Epirubicin—testicular cancer	0.000576	0.000729	CcSEcCtD
Aminophylline—HDAC2—Chromatin modifying enzymes—H2AFZ—testicular cancer	0.000575	0.00927	CbGpPWpGaD
Aminophylline—Hypotension—Methotrexate—testicular cancer	0.000575	0.000728	CcSEcCtD
Aminophylline—Infection—Epirubicin—testicular cancer	0.000572	0.000724	CcSEcCtD
Aminophylline—Shock—Epirubicin—testicular cancer	0.000567	0.000717	CcSEcCtD
Aminophylline—Convulsion—Doxorubicin—testicular cancer	0.000566	0.000716	CcSEcCtD
Aminophylline—Nervous system disorder—Epirubicin—testicular cancer	0.000565	0.000715	CcSEcCtD
Aminophylline—Tachycardia—Epirubicin—testicular cancer	0.000562	0.000711	CcSEcCtD
Aminophylline—Insomnia—Methotrexate—testicular cancer	0.000557	0.000704	CcSEcCtD
Aminophylline—Anxiety—Doxorubicin—testicular cancer	0.000554	0.000701	CcSEcCtD
Aminophylline—Anorexia—Epirubicin—testicular cancer	0.000549	0.000695	CcSEcCtD
Aminophylline—HDAC2—Transcription—H2AFZ—testicular cancer	0.000547	0.00881	CbGpPWpGaD
Aminophylline—Dyspepsia—Methotrexate—testicular cancer	0.000542	0.000686	CcSEcCtD
Aminophylline—Hypotension—Epirubicin—testicular cancer	0.000538	0.000681	CcSEcCtD
Aminophylline—ADORA2A—GPCR downstream signaling—INSL3—testicular cancer	0.000536	0.00864	CbGpPWpGaD
Aminophylline—Decreased appetite—Methotrexate—testicular cancer	0.000535	0.000677	CcSEcCtD
Aminophylline—Anaphylactic shock—Doxorubicin—testicular cancer	0.000533	0.000674	CcSEcCtD
Aminophylline—Infection—Doxorubicin—testicular cancer	0.00053	0.00067	CcSEcCtD
Aminophylline—Shock—Doxorubicin—testicular cancer	0.000525	0.000664	CcSEcCtD
Aminophylline—Nervous system disorder—Doxorubicin—testicular cancer	0.000523	0.000661	CcSEcCtD
Aminophylline—Insomnia—Epirubicin—testicular cancer	0.000521	0.000659	CcSEcCtD
Aminophylline—Tachycardia—Doxorubicin—testicular cancer	0.00052	0.000658	CcSEcCtD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000513	0.00826	CbGpPWpGaD
Aminophylline—Anorexia—Doxorubicin—testicular cancer	0.000508	0.000643	CcSEcCtD
Aminophylline—Dyspepsia—Epirubicin—testicular cancer	0.000507	0.000642	CcSEcCtD
Aminophylline—Gastrointestinal pain—Methotrexate—testicular cancer	0.000503	0.000637	CcSEcCtD
Aminophylline—Decreased appetite—Epirubicin—testicular cancer	0.000501	0.000634	CcSEcCtD
Aminophylline—Hypotension—Doxorubicin—testicular cancer	0.000498	0.00063	CcSEcCtD
Aminophylline—Urticaria—Methotrexate—testicular cancer	0.000489	0.000619	CcSEcCtD
Aminophylline—ADORA2A—Signaling by GPCR—INSL3—testicular cancer	0.000487	0.00785	CbGpPWpGaD
Aminophylline—Abdominal pain—Methotrexate—testicular cancer	0.000487	0.000616	CcSEcCtD
Aminophylline—Body temperature increased—Methotrexate—testicular cancer	0.000487	0.000616	CcSEcCtD
Aminophylline—Insomnia—Doxorubicin—testicular cancer	0.000482	0.00061	CcSEcCtD
Aminophylline—Gastrointestinal pain—Epirubicin—testicular cancer	0.000471	0.000596	CcSEcCtD
Aminophylline—Dyspepsia—Doxorubicin—testicular cancer	0.000469	0.000594	CcSEcCtD
Aminophylline—Decreased appetite—Doxorubicin—testicular cancer	0.000463	0.000586	CcSEcCtD
Aminophylline—Urticaria—Epirubicin—testicular cancer	0.000458	0.000579	CcSEcCtD
Aminophylline—Body temperature increased—Epirubicin—testicular cancer	0.000456	0.000576	CcSEcCtD
Aminophylline—Abdominal pain—Epirubicin—testicular cancer	0.000456	0.000576	CcSEcCtD
Aminophylline—HDAC2—Direct p53 effectors—MMP2—testicular cancer	0.000454	0.00732	CbGpPWpGaD
Aminophylline—Hypersensitivity—Methotrexate—testicular cancer	0.000454	0.000574	CcSEcCtD
Aminophylline—ADORA2B—Signaling Pathways—INSL3—testicular cancer	0.000438	0.00706	CbGpPWpGaD
Aminophylline—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000436	0.000552	CcSEcCtD
Aminophylline—Pruritus—Methotrexate—testicular cancer	0.000436	0.000551	CcSEcCtD
Aminophylline—HDAC2—Gene Expression—DNMT3L—testicular cancer	0.000435	0.00701	CbGpPWpGaD
Aminophylline—Hypersensitivity—Epirubicin—testicular cancer	0.000425	0.000537	CcSEcCtD
Aminophylline—HDAC2—Signaling by NGF—KITLG—testicular cancer	0.000424	0.00684	CbGpPWpGaD
Aminophylline—Urticaria—Doxorubicin—testicular cancer	0.000424	0.000536	CcSEcCtD
Aminophylline—Body temperature increased—Doxorubicin—testicular cancer	0.000421	0.000533	CcSEcCtD
Aminophylline—Abdominal pain—Doxorubicin—testicular cancer	0.000421	0.000533	CcSEcCtD
Aminophylline—Diarrhoea—Methotrexate—testicular cancer	0.000421	0.000533	CcSEcCtD
Aminophylline—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	0.000418	0.00674	CbGpPWpGaD
Aminophylline—Pruritus—Epirubicin—testicular cancer	0.000408	0.000516	CcSEcCtD
Aminophylline—Dizziness—Methotrexate—testicular cancer	0.000407	0.000515	CcSEcCtD
Aminophylline—CYP2E1—Biological oxidations—HPGDS—testicular cancer	0.000407	0.00655	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—INSL3—testicular cancer	0.000398	0.00641	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—KITLG—testicular cancer	0.000395	0.00635	CbGpPWpGaD
Aminophylline—Diarrhoea—Epirubicin—testicular cancer	0.000394	0.000499	CcSEcCtD
Aminophylline—Hypersensitivity—Doxorubicin—testicular cancer	0.000393	0.000497	CcSEcCtD
Aminophylline—Vomiting—Methotrexate—testicular cancer	0.000391	0.000495	CcSEcCtD
Aminophylline—Rash—Methotrexate—testicular cancer	0.000388	0.000491	CcSEcCtD
Aminophylline—Dermatitis—Methotrexate—testicular cancer	0.000388	0.000491	CcSEcCtD
Aminophylline—PDE3A—Signaling Pathways—INSL3—testicular cancer	0.000387	0.00624	CbGpPWpGaD
Aminophylline—Headache—Methotrexate—testicular cancer	0.000386	0.000488	CcSEcCtD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000381	0.00614	CbGpPWpGaD
Aminophylline—Dizziness—Epirubicin—testicular cancer	0.000381	0.000482	CcSEcCtD
Aminophylline—Pruritus—Doxorubicin—testicular cancer	0.000377	0.000477	CcSEcCtD
Aminophylline—ADORA1—Signaling Pathways—INSL3—testicular cancer	0.000373	0.006	CbGpPWpGaD
Aminophylline—Vomiting—Epirubicin—testicular cancer	0.000366	0.000463	CcSEcCtD
Aminophylline—Nausea—Methotrexate—testicular cancer	0.000366	0.000463	CcSEcCtD
Aminophylline—Diarrhoea—Doxorubicin—testicular cancer	0.000365	0.000461	CcSEcCtD
Aminophylline—Rash—Epirubicin—testicular cancer	0.000363	0.00046	CcSEcCtD
Aminophylline—Dermatitis—Epirubicin—testicular cancer	0.000363	0.000459	CcSEcCtD
Aminophylline—Headache—Epirubicin—testicular cancer	0.000361	0.000457	CcSEcCtD
Aminophylline—Dizziness—Doxorubicin—testicular cancer	0.000353	0.000446	CcSEcCtD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.00035	0.00564	CbGpPWpGaD
Aminophylline—Nausea—Epirubicin—testicular cancer	0.000342	0.000433	CcSEcCtD
Aminophylline—Vomiting—Doxorubicin—testicular cancer	0.000339	0.000429	CcSEcCtD
Aminophylline—Rash—Doxorubicin—testicular cancer	0.000336	0.000425	CcSEcCtD
Aminophylline—Dermatitis—Doxorubicin—testicular cancer	0.000336	0.000425	CcSEcCtD
Aminophylline—Headache—Doxorubicin—testicular cancer	0.000334	0.000423	CcSEcCtD
Aminophylline—Nausea—Doxorubicin—testicular cancer	0.000317	0.000401	CcSEcCtD
Aminophylline—HDAC2—Signaling by NGF—FGFR3—testicular cancer	0.000315	0.00508	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—INSL3—testicular cancer	0.00031	0.00499	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—FGFR3—testicular cancer	0.000293	0.00472	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—KIT—testicular cancer	0.00029	0.00466	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—INSL3—testicular cancer	0.000288	0.00463	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—KIT—testicular cancer	0.000269	0.00434	CbGpPWpGaD
Aminophylline—CYP1A2—Biological oxidations—HPGDS—testicular cancer	0.000245	0.00394	CbGpPWpGaD
Aminophylline—CYP3A4—Biological oxidations—HPGDS—testicular cancer	0.000189	0.00304	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—H2AFZ—testicular cancer	0.000152	0.00245	CbGpPWpGaD
Aminophylline—HDAC2—Disease—H2AFZ—testicular cancer	0.000141	0.00228	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—H2AFZ—testicular cancer	0.00014	0.00226	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—STK11—testicular cancer	0.00014	0.00225	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KITLG—testicular cancer	0.00013	0.0021	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KITLG—testicular cancer	0.000129	0.00208	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—H2AFZ—testicular cancer	0.000127	0.00205	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—STK11—testicular cancer	0.000127	0.00204	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—H2AFZ—testicular cancer	0.000124	0.002	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—STK11—testicular cancer	0.000123	0.00198	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—H2AFZ—testicular cancer	0.000119	0.00192	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—STK11—testicular cancer	0.000119	0.00191	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KITLG—testicular cancer	0.000117	0.00189	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KITLG—testicular cancer	0.000114	0.00184	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KITLG—testicular cancer	0.00011	0.00177	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—H2AFZ—testicular cancer	9.91e-05	0.0016	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—STK11—testicular cancer	9.85e-05	0.00159	CbGpPWpGaD
Aminophylline—HDAC2—Disease—FGFR3—testicular cancer	9.67e-05	0.00156	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—FGFR3—testicular cancer	9.59e-05	0.00155	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	9.39e-05	0.00151	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—H2AFZ—testicular cancer	9.21e-05	0.00148	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—STK11—testicular cancer	9.16e-05	0.00148	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KITLG—testicular cancer	9.12e-05	0.00147	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KIT—testicular cancer	8.88e-05	0.00143	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KIT—testicular cancer	8.81e-05	0.00142	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—FGFR3—testicular cancer	8.71e-05	0.0014	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—FGFR3—testicular cancer	8.47e-05	0.00136	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KITLG—testicular cancer	8.47e-05	0.00136	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—FGFR3—testicular cancer	8.16e-05	0.00131	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KIT—testicular cancer	8e-05	0.00129	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KIT—testicular cancer	7.78e-05	0.00125	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KIT—testicular cancer	7.49e-05	0.00121	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—HPGDS—testicular cancer	6.96e-05	0.00112	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—FGFR3—testicular cancer	6.77e-05	0.00109	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—FGFR3—testicular cancer	6.3e-05	0.00101	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KIT—testicular cancer	6.22e-05	0.001	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KIT—testicular cancer	5.78e-05	0.000931	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—STK11—testicular cancer	5.06e-05	0.000814	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—HPGDS—testicular cancer	4.18e-05	0.000674	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—HPGDS—testicular cancer	3.23e-05	0.00052	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—STK11—testicular cancer	3.04e-05	0.00049	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—STK11—testicular cancer	2.35e-05	0.000378	CbGpPWpGaD
